NI
NeuroGeneces, Inc.
SEC filingOther Health Care · Santa Fe, NM
Amount raised$425Ksold at filing
Total offering$750K$325K still open
Investors in the raise13count reported to the SEC
FiledMay 1, 2026first sale Nov 14, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Karen CrowExecutive Officer, Director
Barry Jason WorchelExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.